Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransCode Therapeutics, Inc. - Common Stock (NQ:RNAZ)

4.250 -0.200 (-4.49%)
Streaming Delayed Price Updated: 3:59 PM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TransCode Therapeutics, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Longeveron (NASDAQ:LGVN) shares ... 
Via Benzinga
News headline image
TransCode Therapeutics Appoints Zdravka Medarova, Ph.D., as Chief Technology Officer
From TransCode Therapeutics, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Regencell Bioscience (NASDAQ:RGC)... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Geovax Labs (NASDAQ:GOVX) shares... 
Via Benzinga
News headline image
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
News headline image
48 Biggest Movers From Friday ↗
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares climbed 58% to close at $5.45 on Friday. Clearwater Analytics Holdings, Inc. (NYSE: CWAN) surged 40.9% to settle at $25.37... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Molecular Templates (NASDAQ:MTEM) stock rose 14.13% to $7.59 during Friday's regular session. Trading volume for Molecular Templates's stock is 937.9K as... 
Via Benzinga
News headline image
34 Stocks Moving In Friday's Mid-Day Session ↗
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares jumped 76.2% to $6.08. Unique Fabricating, Inc. (NASDAQ: UFAB) jumped 37.7% to $3.47. Form 4 filings from late Thursday... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Cellect Biotechnology (NASDAQ:APOP) stock moved upwards by 251.16% to $21.07 during Friday's pre-market session. The company's market cap stands at $82.6... 
Via Benzinga
News headline image
22 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 42% to $15.24 in pre-market trading. The company’s shares jumped around 65% over the previous month. vTv Therapeutics Inc... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Crude Oil Surges 1.5%; BlackBerry Shares Spike Higher ↗
Toward the end of trading Thursday, the Dow traded up 1.63% to 34,816.83 while the NASDAQ rose 1.13% to 15,065.80. The S&P also rose, gaining 1.41% to 4,457.72. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
RNAZ Stock Alert: The Breast Cancer Study News Sending TransCode Therapeutics Soaring Today ↗
TransCode Therapeutics (RNAZ) stock is rocketing higher on Thursday as investors react to positive news from a breast cancer study. 
Via InvestorPlace
News headline image
58 Biggest Movers From Yesterday ↗
Gainers MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares surged 73.4% to close at $12.80 on Thursday following news the company will buy ZACC Kabushiki Kaisha for $3.362... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers TransCode Therapeutics (NASDAQ:RNAZ) stock rose 94.3% to $5.09 during Thursday's regular session. TransCode Therapeutics's stock is trading at a volume of... 
Via Benzinga
News headline image
Mid-Day Market Update: Dow Jumps Over 500 Points; Eargo Shares Plunge ↗
Midway through trading Thursday, the Dow traded up 1.58% to 34,798.08 while the NASDAQ rose 1.02% to 15,048.82. The S&P also rose, gaining 1.33% to 4,454.02. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
38 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares jumped 101% to $14.87 following news the company will buy ZACC Kabushiki Kaisha for $3.362 million. TransCode... 
Via Benzinga
News headline image
Why Are TransCode Therapeutics Shares Shooting Higher On Thursday? ↗
TransCode Therapeutics Inc (NASDAQ: RNAZ) is trading higher after preclinical research supporting its lead candidate, TTX-MC138, was published in Cancer Nanotechnology... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Open Higher; Accenture Profit Beats Views ↗
Following the market opening Thursday, the Dow traded up 1.38% to 34,732.57 while the NASDAQ rose 0.97% to 15,041.00. The S&P also rose, gaining 1.22% to 4,449.12. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 23.66% to $3.24 during Thursday's pre-market session. The company's market cap stands at $41.8... 
Via Benzinga
News headline image
TransCode Therapeutics Announces Publication in Cancer Nanotechnology of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Metastatic Breast Cancer
From TransCode Therapeutics, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Cardiff Oncology (NASDAQ: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Regencell Bioscience (NASDAQ:RGC)... 
Via Benzinga
News headline image
20 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers Baudax Bio, Inc. (NASDAQ: BXRX) rose 48.3% to $0.777 in pre-market trading after gaining over 3% on Monday. The company, earlier during the month, reported downbeat... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Cara Therapeutics (NASDAQ:CARA) ... 
Via Benzinga
News headline image
TransCode Therapeutics Reports Business Progress and Second Quarter 2021 Financial Results
From TransCode Therapeutics, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
On Monday morning, 207 companies hit new 52-week lows. Intriguing Points: The largest company in terms of market cap to set a new 52-week low was Koninklijke Philips (NYSE... 
Via Benzinga
News headline image
TransCode Therapeutics Secures NIH Funding To Support Its Lead Program Development ↗
TransCode Therapeutics Inc (NASDAQ: RNAZ) has received a Fast-Track Small Business Innovation Research (SBIR) grant from the NIH to support developing TTX-MC138. TTX-MC138... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.